Correlation Between Chunghwa Precision and Handa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Chunghwa Precision and Handa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chunghwa Precision and Handa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Chunghwa Precision Test and Handa Pharmaceuticals, you can compare the effects of market volatilities on Chunghwa Precision and Handa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chunghwa Precision with a short position of Handa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chunghwa Precision and Handa Pharmaceuticals.

Diversification Opportunities for Chunghwa Precision and Handa Pharmaceuticals

0.04

Correlation Coefficient

Chunghwa Precision  Handa Pharmaceuticals

Significant diversification

The 3 months correlation between Chunghwa and Handa is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Chunghwa Precision Test and Handa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Handa Pharmaceuticals and Chunghwa Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chunghwa Precision Test are associated (or correlated) with Handa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Handa Pharmaceuticals has no effect on the direction of Chunghwa Precision i.e., Chunghwa Precision and Handa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Chunghwa Precision and Handa Pharmaceuticals

Assuming the 90 days trading horizon Chunghwa Precision Test is expected to generate 0.86 times more return on investment than Handa Pharmaceuticals. However, Chunghwa Precision Test is 1.16 times less risky than Handa Pharmaceuticals. It trades about 0.17 of its potential returns per unit of risk. Handa Pharmaceuticals is currently generating about 0.1 per unit of risk. If you would invest  56,900  in Chunghwa Precision Test on October 23, 2024 and sell it today you would earn a total of  26,100  from holding Chunghwa Precision Test or generate 45.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Chunghwa Precision Test  vs.  Handa Pharmaceuticals

Chunghwa Precision Test

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Chunghwa Precision Test are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Chunghwa Precision showed solid returns over the last few months and may actually be approaching a breakup point.

Handa Pharmaceuticals

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Handa Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Handa Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Chunghwa Precision and Handa Pharmaceuticals

The main advantage of trading using opposite Chunghwa Precision and Handa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chunghwa Precision position performs unexpectedly, Handa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Handa Pharmaceuticals will offset losses from the drop in Handa Pharmaceuticals' long position.

The idea behind Chunghwa Precision Test and Handa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.